Moderna, Inc. (MRNA)

Healthcare

$189.80

LAST CLOSE · OCT 1

Moderna, Inc. (MRNA) is a Healthcare stock tracked by StreetAlpha. It last closed at $189.80 on Oct 1. MRNA reports earnings on Thu, Nov 5, 2026. The average 12-month price target from 10 analysts is $98.50 (-48.1% from the last close), with a high of $180.00 and a low of $38.00. Analyst consensus is Hold, based on the latest ratings from 10 firms (1 buy, 5 hold, 4 sell). Over the past 90 days StreetAlpha recorded 85 whale options trades in MRNA, 49% of them bullish and 51% bearish. In the past 30 days there were 56 dark pool prints totaling $71.9M, the largest $6.3M.

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions.

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRNA is in one of them and how their past MRNA trades turned out.

StreetAlpha hasn't covered MRNA in an article yet. Here's the latest on the wider market.